Test Price
2,800 AED✅ Home Collection Available
P2RY12 Gene Platelet-Type 8 Bleeding Disorder DNA Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Core Metrics
Next-generation sequencing of the P2RY12 gene with 99.9% diagnostic sensitivity, ISO-accredited laboratory processing, VIP mobile phlebotomy home collection, and telephonic post-test guidance from Consultant Medical Genetics. Direct insurance billing verification supported.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License 1143
Test Overview & Methodology
P2RY12 Gene Platelet-Type 8 Bleeding Disorder Genetic Test detects pathogenic variants in the P2RY12 gene using next-generation sequencing, enabling precise diagnosis and tailored management of this rare inherited platelet disorder. The assay covers all coding regions and flanking intronic boundaries to ensure comprehensive variant detection.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision | Full-gene NGS, all coding regions ± flanking introns | Single-gene Sanger, limited to hotspot exons |
| Methodology | ISO 9001:2015 NGS (LC-MS/MS-validated) | Conventional PCR + Sanger |
| Turnaround Time | 3–4 Weeks (14–21 Business Days) | 4–6 Weeks |
| Sample Options | Whole Blood, Extracted DNA, or One-drop Blood on FTA Card | Whole Blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403 — “A positive P2RY12 variant provides a definitive molecular diagnosis for platelet-type bleeding disorder and guides personalized management. However, a negative result does not exclude platelet dysfunction; always correlate with light transmission aggregometry and bleeding assessment tools. Genetic counseling for at-risk family members is strongly recommended. Do not modify antiplatelet therapy solely based on genetic data.”
Advisory Notice
⚠️ Clinical Notice
Do not discontinue or modify any prescribed medication, including antiplatelet agents, without consulting your referring physician. Genetic test results are one component of a comprehensive hemostatic evaluation.
Safety Exclusion Criteria & Emergency Red Flags
🚨 Exclusion & Emergency Indicators
- Exclusion: Active uncontrolled bleeding requiring immediate medical intervention; platelet transfusion within the past 7 days.
- Emergency Red Flags (visit ER immediately): Sudden severe headache, vision loss, slurred speech, uncontrolled bleeding from any site, or blood in urine/stool.
Patient FAQ & Clinical Guidance
1. What is the P2RY12 gene test and why is it important for bleeding disorders?
The P2RY12 gene test sequences the entire coding region using NGS to identify inherited mutations that cause platelet aggregation defects. This helps confirm a diagnosis of platelet-type 8 bleeding disorder, guides personalised treatment strategies, and informs family screening. A negative result may still require platelet function studies, so clinical follow-up is essential.
2. How is the test performed and what sample is needed?
A simple blood draw, a drop of blood on an FTA card, or submitting previously extracted DNA are all acceptable sample types for this test. Our VIP mobile phlebotomy team visits your home between 8 AM and 11 PM, ensuring cold-chain transport to our ISO-accredited laboratory. No fasting is required; however, a genetic counseling session is advised beforehand to map the family pedigree.
3. How long do results take and what do they mean for my health?
Results are typically ready in 3 to 4 weeks, and a positive finding pinpoints the exact genetic cause of your bleeding tendency. Your physician will interpret the variant alongside your bleeding history and platelet function tests to determine appropriate precautions, possible treatment adjustments, and familial screening. You will also receive a telephonic post-test clinical guidance session to discuss the implications with a specialist.
UAE Regulatory & Data Privacy Adherence
✅ Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed within the UAE under strict confidentiality protocols. Specimen handling and patient consent procedures adhere to UAE healthcare data protection standards.
Clinical & Logistical Metadata
| Test Name | P2RY12 Gene Platelet-Type 8 Bleeding Disorder DNA Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 14–21 Business Days (3–4 Weeks) |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | D69.1 (Qualitative platelet defects) |
| LOINC Code | 92940-1 (Gene mutations found in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians